managing high-risk cll
Published 6 years ago • 171 plays • Length 4:42Download video MP4
Download video MP3
Similar videos
-
5:01
embracing newer therapies in high-risk cll
-
5:31
what is high-risk cll and how is it treated?
-
5:12
high-risk chronic lymphocytic leukemia
-
20:43
r/r high risk cll: personalized management based on patient characteristics and cytogenetics
-
2:53
therapeutic options for high-risk cll
-
2:22
igvh and other high-risk cytogenetic risk factors in cll
-
1:00:05
chronic lymphocytic leukemia (cll): what it is when to treat and what’s ahead
-
21:13
breakthrough cll treatments: the latest advances in chronic lymphocytic leukemia | the patient story
-
11:54
chronic lymphocytic leukemia - a treatable cancer | क्रोनिक लिम्फोसाइटिक ल्यूकेमिया
-
1:41
treating high risk cll with btk inhibitors
-
2:01
impact of comorbidities on patient selection for combination therapies in cll
-
2:43
outcomes in high-risk cll patients following fixed-duration treatment with ibrutinib plus venetoclax
-
2:42
exploring early ibrutinib intervention in high-risk cll
-
4:46
further improving the management of cll
-
4:49
risk stratification for a patient with cll
-
4:18
what does it mean to have high-risk cll?
-
5:55
case 1: an elderly patient with newly diagnosed high-risk cll
-
53:40
finding treatment synergy in cll
-
6:26
managing elderly patients with cll
-
4:27
stratifying patients with cll by stage and risk status
-
3:48
managing cll treatment in the future: targeted therapies and early intervention
-
1:36
dr. brander on the treatment landscape for patients with high-risk cll